Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sosei buys Arakis for £106.5mm

Executive Summary

As part of its effort to move into the top-ten list of biopharmaceutical firms worldwide, Japanese pharma company Sosei Ltd. Co. has agreed to acquire all of the shares of privately held Arakis Ltd. (inflammatory diseases, cancer, and pain) for £106.5mm ($186.1mm) in cash and stock.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Intra-Biotech Deal
    • Acquisition of Private Biotech
    • Payment Includes Stock
    • Full Acquisition
    • Payment Includes Cash

Related Companies

Advertisement
UsernamePublicRestriction

Register